Professor Aaron Ciechanover, Executive consultant

Prof. Ciechanover is the Co-discoverer of the Ubiquitin-proteasome system and the 2004 Nobel Prize laureate in chemistry. He has authored more than 250 publications in the field of protein degradation and served on the Scientific Advisory Boards of several companies including Rosetta Genomics (Chairman), BioLineRx, Ltd, StemRad, Ltd, Allosterix Ltd, Proteologics, Inc, MultiGene Vascular Systems, Ltd, Protalix BioTherapeutics, BioTheryX, Inc., and Haplogen,GmbH. Professor Ciechanover is currently a Distinguished Research Professor at the Cancer and Vascular Biology Research Center of the Rappaport Research Institute and Faculty of Medicine at the Technion-Israel Institute of Technology.

​

​

​

​

​

​